Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

420 results about "Hearing loss" patented technology

Any degree of impairment of the ability to apprehend sound.

Method and system for hearing device fitting

The method for manufacturing an adjusted hearing device (1b) comprises the step of using first data (16a) obtained from a first hearing device (1a) adjusted to the preferences of a first user (5a) for adjusting a second hearing device (1b) of a second user (5b). This may comprise converting for compensating for differences between a hearing loss of said first user and a hearing loss of said second user and / or converting for compensating for differences between said first hearing device and said second hearing device. Preferably, said first data comprise fitting data (16). The system comprises a first hearing device (1a), a second hearing device (1b) and a converting system (15) operationally connectable to said first and said second hearing devices, adapted to converting first data (16a) from said first hearing device into second data (16b) for adjusting said second hearing device. Preferably, the system also comprises a communication link (7) between said first hearing device and said second hearing device. The invention allows different hearing device users to share their fitting data.
Owner:PHONAK

Binaural adaptive hearing aid

A system and method for processing an acoustic input signal and providing at least one output acoustic signal to a user of a hearing-aid system. The hearing-aid system includes first and second channels with one of the channels having an adaptive delay. The first channel includes a directional unit for receiving the acoustic input signal and providing a directional signal; a correlative unit for receiving the directional signal and providing a noise reduced signal by utilizing correlative measures for identifying a speech signal of interest in the directional signal; and, a compensator for receiving the noise reduced signal and providing a compensated signal for compensating for a hearing loss of the user.
Owner:MCMASTER UNIV

Tinnitus rehabilitation device and method

A tinnitus method and device for providing relief to a person suffering from the disturbing effects of tinnitus is described. The method can be implemented entirely in software to spectrally modify an audio signal in accordance with a predetermined masking algorithm which modifies the intensity of the audio signal at selected frequencies. A predetermined masking algorithm is described which provides intermittent masking of the tinnitus wherein, at a comfortable listening level, during peaks of the audio signal the tinnitus is completely obscured, whereas during troughs the perception of the tinnitus occasionally emerges. In practice it has been found that such intermittent masking provides an immediate sense of relief, control and relaxation for the person, whilst enabling sufficient perception of the tinnitus for habituation and long term treatment to occur. Advantageously the predetermined masking algorithm is specifically tailored to the audiometric configuration of the person. For example, the masking algorithm may be partly tailored to the hearing loss characteristic of the person. A tinnitus rehabilitation device used in conjunction with a personal sound reproducing system is also described.
Owner:NEUROMONICS

Sound enhancement for mobile phones and other products producing personalized audio for users

A mobile phone or other personal communication device includes resources applying measures of an individual's hearing profile, personal choice profile, and induced hearing loss profile, separately or in combination, to build the basis of sound enhancement. A personal communication device thus comprises a transmitter / receiver coupled to a communication medium for transmitted receiving audio signals, control circuitry that controls transmission, reception and processing of call and audio signals, a speaker, and a microphone. The control circuitry includes logic applying one or more of a hearing profile of the user, a user preference related hearing, and environmental noise factors in processing the audio signals. The control circuitry may includes instruction memory and an instruction execution processor such as a digital signal processor.
Owner:HIMPP

Hybrid cochlear/vestibular implant

A system for treating patients affected both by hearing loss and by balance disorders related to vestibular hypofunction and / or malfunction, which includes sensors of sound and head movement, processing circuitry, a power source, and an implantable electrical stimulator capable of stimulating areas of the cochlea and areas of the vestibular system.
Owner:THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

Tinnitus rehabilitation device and method

A tinnitus method and device for providing relief to a person suffering from the disturbing effects of tinnitus is described. The method can be implemented entirely in software to spectrally modify an audio signal in accordance with a predetermined masking algorithm which modifies the intensity of the audio signal at selected frequencies. A predetermined masking algorithm is described which provides intermittent masking of the tinnitus wherein, at a comfortable listening level, during peaks of the audio signal the tinnitus is completely obscured, whereas during troughs the perception of the tinnitus occasionally emerges. In practice it has been found that such intermittent masking provides an immediate sense of relief, control and relaxation for the person, whilst enabling sufficient perception of the tinnitus for habituation and long term treatment to occur. Advantageously the predetermined masking algorithm is specifically tailored to the audiometric configuration of the person. For example, the masking algorithm may be partly tailored to the hearing loss characteristic of the person. A tinnitus rehabilitation device used in conjunction with a personal sound reproducing system is also described.
Owner:NEUROMONICS

Intracochlear Nanotechnology and Perfusion Hearing Aid Device

An intra-cochlear implant is provided for aiding in the hearing of a patient. The implant includes a body portion implantable within an interior of a cochlea of a patient. The body portion has a proximal end, a distal end and a primary axis. A plurality of signal carrying electrodes extends along the body portion. The electrodes have proximal ends and distal ends, with the proximal ends being capable of receiving a signal from a signal generator, and the distal ends being capable of delivering the received signal to an anatomical receptor within a cochlea. At least several of the plurality of electrodes have a nanoelectrode-sized portion. The implant also may include a fluid delivery system of tubules, reservoirs, and pumps for the delivery of chemicals and cells to activate regeneration of neural elements lost during the hearing loss process.
Owner:DOMESTIC ASSET LLP

Tinnitus rehabilitation device and method

A tinnitus method and device for providing relief to a person suffering from the disturbing effects of tinnitus is described. The method can be implemented entirely in software to spectrally modify an audio signal in accordance with a predetermined masking algorithm which modifies the intensity of the audio signal at selected frequencies. A predetermined masking algorithm is described which provides intermittent masking of the tinnitus wherein, at a comfortable listening level, during peaks of the audio signal the tinnitus is completely obscured, whereas during troughs the perception of the tinnitus occasionally emerges. In practice it has been found that such intermittent masking provides an immediate sense of relief, control and relaxation for the person, whilst enabling sufficient perception of the tinnitus for habituation and long term treatment to occur. Advantageously the predetermined masking algorithm is specifically tailored to the audiometric configuration of the person. For example, the masking algorithm may be partly tailored to the hearing loss characteristic of the person. A tinnitus rehabilitation device used in conjunction with a personal sound reproducing system is also described.
Owner:NEUROMONICS

Dual Cochlear/Vestibular Stimulator with Control Signals Derived from Motion and Speech Signals

A system for treating patients affected both by hearing loss and by balance disorders related to vestibular hypofunction and / or malfunction, which includes sensors of sound and head movement, processing circuitry, a power source, and an implantable electrical stimulator capable of stimulating areas of the cochlea and areas of the vestibular system.
Owner:ADVNACED BIONICS LLC +1

Personal communication device with hearing support and method for providing the same

A personal communication device provides hearing support, and includes an input receiving an audio signal, a programmable processor, and an output outputting the processed signal. The programmable processor performs a filtering operation on a digital version of the audio signal in a first signal path based on parameter settings and provides control logic that determines the parameter settings based on information on user preferences, on audiological information and on information on the listening situation to provide hearing loss compensation. The programmable processor has a second signal path in parallel with the first signal path that receives the digital version of the audio signal and parameter settings and determining the filter coefficients of the filtering operation based on the parameter settings and the digital version of the audio signal.
Owner:JACOTI

Method for treating hearing loss

InactiveUS20070135870A1Improve hearing lossSurgical instrument detailsLight therapyHand heldCranial nerves
A method for treating a patient with laser energy to improve hearing loss. The method involves applying laser energy to the patient's spine, preferably by sweeping a linear laser beam over the patient's skin. The method may alternatively include applying laser energy to the patient's jaw, skull, ears, or a combination thereof. The laser device used for treating the patient is preferably a hand-held probe that moves freely relative to the patient's skin and can generate more than one wavelength of laser energy. In the preferred treatment, the patient is treated with a hand-held probe that emits two laser beams, one laser beam producing a pulsed line of red laser light and the other producing a pulsed line of green laser light. In the preferred embodiment, the patient's upper back, cervical vertebrae, cranial nerves, and temporomandibular joints are treated with laser energy for a total of less than 20 minutes in a single treatment.
Owner:HEARINGMED LASER TECH +1

Tinnitus masking systems

InactiveUS20090147976A1Defocus their attention to the tinnitusElectric tinnitus maskersTeeth fillingOral applianceTransducer
Tinnitus masking systems for treating tinnitus are described where a device is coupled to a surface of a bone or to a tooth or several teeth. Such a device may comprise an oral appliance having an electronic and / or transducer assembly for generating sounds via a vibrating transducer element. Generally, the transducer may generate one or more frequencies of sound via the actuatable transducer to transmit a modified audio signal via vibratory conductance to an inner ear of the patient to mask tinnitus during a peak of the audio signal and to allow the user to perceive the tinnitus during a trough of the audio signal. The audio signal is also modified to account for any hearing loss of the patient as well as a bone conductance profile measured from the patient.
Owner:SOUNDMED LLC

Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus

The invention defines interdependent biofactors and biomolecules, and clinically useful formulations that are comprised of them. The active agents are demonstrated to be complementary in their physiologic functions especially as these relate to the quenching of free radicals and to the support of endothelial physiology, the reduction of hyperinsulinemia and improvements in vascular health. The active components of the invention are selected for inclusion in precise combinations specifically because they improve these various conditions and physiological functions, and by so doing reduce a variety of risks associated with hearing loss and tinnitus. The resulting enhancement of general systemic vascular health, improvement in local VIIIth nerve vascular health, modulation of conditions surrounding blood fluid dynamics, the consequences of hyperinsulinemia, and improvements in free radical defenses, all reduce the potential for cochlear hair cell death and VIIIth nerve atrophy, and the hearing loss and possible deafness that accompany them.
Owner:CHRONORX

DSP-enabled amplified telephone with digital audio processing

A DSP-enabled system and method for increasing intelligibility of audio on amplified telephones by providing digital audio processing customizable based on characteristics of hearing loss specific to individual end users are disclosed. The DSP-enabled amplified telephone generally comprises a DSP capable of implementing at least one digital processing mode for processing audio input, a volume control for allowing the user to select a volume control level, and a controller for interfacing between the DSP and the volume control. The DSP is optionally programmable to implement a processing mode selected from multiple processing modes that the DSP is capable of implementing. The mode is selected based upon the user's hearing loss characteristics. The DSP may be further customized by being programmed with frequency response, compression ratio, and / or knee point according to hearing loss characteristics of the user. The DSP may implement digital TILL, BILL, and / or PILL (treble, bass, and programmable increase at low levels, respectively), all of which apply more amplification to softer inputs than to louder inputs, as well as input compression, output compression, and / or finite impulse response (FIR) filter tone control.
Owner:PLANTRONICS

Use of R (+) -N-propargyl-1-aminoindan to treat or prevent hearing loss

A method of treating or inhibiting hearing loss in a mammalian subject, comprising administering to the subject an amount of R(+)-N-propargyl-1-aminoindan or pharmaceutically acceptable salt thereof effective to treat or inhibit the hearing loss in the subject.
Owner:TEVA PHARMA IND LTD

Digital cell phone with hearing aid functionality

A digital cell phone with built in hearing aid functionality, includes: a housing; a digital signal processor (DSP) contained within the housing for encoding and decoding digital data; a hearing loss compensation module, coupled to the DSP, for processing digital data in accordance with a hearing loss compensation algorithm; a digital-to-analog converter (DAC), coupled to the hearing loss compensation module, for receiving the processed digital data from the hearing loss compensation circuit and converting the data into an analog signal; and a speaker, coupled to the DAC, for receiving the analog signal and converting the analog signal into sound waves adapted for a hearing impaired listener.
Owner:AUDIGICOMM

Coated electrode array having uncoated electrode contacts

Implantable electrode leads, e.g. cochlear, spinal cord stimulation, or any type of neurostimulation leads, used in a patient's body to stimulate muscle or nerve tissue, provide enhanced stimulation for treating, e.g., hearing loss or chronic pain. One such lead includes, an implantable electrode array, adapted for insertion into a cochlea, which lead provides improved stability of electrode contact direction. In-line electrodes are spaced-apart along one side of a flexible carrier having non-conductive bumps coated with a bioresorbable material spaced apart between each electrode contact. Over time the bioresorbable material is absorbed thereby reducing chronic placement pressure caused during the insertion of the electrode array into the cochlea. The bioresorbable material may also serve as a carrier for drugs or other materials that would improve performance of the electrode for any type of lead.
Owner:ADVANCED BIONICS AG

Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus

InactiveUS6524619B2Increased vulnerabilityImproves NO-dependent vasodilatationSalicyclic acid active ingredientsBiocideWhole bodyActive agent
The invention defines interdependent biofactors and biomolecules, and clinically useful formulations that are comprised of them. The active agents are demonstrated to be complementary in their physiologic functions especially as these relate to the quenching of free radicals and to the support of endothelial physiology, the reduction of hyperinsulinemia and improvements in vascular health. The active components of the invention are selected for inclusion in precise combinations specifically because they improve these various conditions and physiological functions, and by so doing reduce a variety of risks associated with hearing loss and tinnitus. The resulting enhancement of general systemic vascular health, improvement in local VIIIth nerve vascular health, modulation of conditions surrounding blood fluid dynamics, the consequences of hyperinsulinemia, and improvements in free radical defenses, all reduce the potential for cochlear hair cell death and VIIIth nerve atrophy, and the hearing loss and possible deafness that accompany them.
Owner:CHRONORX

Personal communication device with hearing support and method for providing the same

The present invention is related to a personal communication device arranged for providing hearing support. The personal communication device comprises an input for receiving an audio signal, programmable processing means and an output for outputting the processed signal. The programmable processing means is arranged for performing a filtering operation on a digital version of the audio signal in a first signal path based on parameter settings and for providing control logic for determining the parameter settings based on information on user preferences, on audiological information and on information on the listening situation, in which the personal communication device is used, obtained via sound environment analysis of the received audio signal and / or via sensing means of the personal communication device, so that the programmable processing means is operable as a hearing loss compensation module arranged for outputting a hearing loss compensated signal. The programmable processing means further has a second signal path in parallel with the first signal path, said second signal path comprising a module for transfer function calculation arranged for receiving the digital version of the audio signal and the parameter settings and for determining the filter coefficients of the filtering means based on the parameter settings and the digital version of the audio signal.
Owner:JACOTI

Dual cochlear/vestibular stimulator with control signals derived from motion and speech signals

A system for treating patients affected both by hearing loss and by balance disorders related to vestibular hypofunction and / or malfunction, which includes sensors of sound and head movement, processing circuitry, a power source, and an implantable electrical stimulator capable of stimulating areas of the cochlea and areas of the vestibular system.
Owner:ADVNACED BIONICS LLC +1

Fitting of hearing devices

The present invention relates to recipient fitting of a hearing device. An embodiment of the present invention determines the transmission loss for sound applied to the recipient by the hearing device. Separate gains are then determined for compensating for the determined transmission loss and the measured hearing loss of the recipient. For example, in an embodiment, the hearing device may compensate for transmission losses in a 1:1 manner (i.e., the transmission loss in 100% compensated for). The hearing device may apply a different gain to compensate for the hearing loss, such as a gain that is a fraction (e.g., 33-55%) of the measured hearing loss.
Owner:COCHLEAR LIMITED

RNA interference mediated inhibition of retinolblastoma (RBI) gene expression using short interfering nucleic acid (siNA)

This invention relates to compounds, compositions, and methods useful for modulating retinoblastoma (RB1) gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of retinoblastoma gene expression and / or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of retinoblastoma genes. Such small nucleic acid molecules are useful, for example, for treating, preventing, inhibiting, or reducing hearing loss, deafness, tinnitus, motion and balance disorders, cancer and proliferative diseases and any other disease, condition, trait or indication that can respond to the level of retinoblastoma in a cell or tissue, alone or in combination with other treatments or therapies.
Owner:SIRNA THERAPEUTICS INC

Methods of treating diseases or conditions using mesenchymal stem cells

InactiveUS20120201791A1Treating and preventing autoimmune hearing lossTreating and preventing hearing lossBiocideSenses disorderUlcerative colitisObstructive Pulmonary Diseases
The present invention provides a method of treating or preventing a disease or condition in a patient comprising intravenously administering a therapeutically effective amount of mesenchymal stem cells to the patient, wherein the disease or condition is osteoarthritis, rheumatoid arthritis, multiple sclerosis, stroke, ulcerative colitis, psoriasis, Hashimoto's thyroiditis, atopic dermatitis, allergic rhinitis, chronic obstructive pulmonary disease with bronchial asthma or hearing loss.
Owner:YOO TAI JUNE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products